Parkinson’s Disease Research News

Newsfeed:

  • Exercise can improve non-motor symptoms of Parkinson’s disease
    (IOS Press) Exercise has potential to improve non-motor as well as motor symptoms of Parkinson's disease (PD), including cognitive function, report investigators in a review published in the Journal of Parkinson's Disease. ... read more
    Source: Eureka AlertPublished on 2019-03-04
  • Distinctly human?
      It is often said that Parkinson’s is a ‘distinctly human’ condition. Researchers will write in their reports that other animals do not naturally develop the features of the condition, even at late stages of life. But how true is this statement? Recently, some research has been ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-03-03By Simon
  • Monthly Research Review – February 2019
      At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2019. The post is divided into seven parts based on the type of research: ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-02-28By Simon
  • The Bristol GDNF results
      Today – 27th February, 2019 – the long-awaited results of the Phase II GDNF clinical trial were published. GDNF (or glial cell line-derived neurotrophic factor) is a protein that our bodies naturally produce to nurture and support cells. Extensive preclinical research suggested that ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-02-27By Simon
  • A Gentle Method For Unlocking the Mysteries of the Deep Brain
    Researchers report EEG technology has the ability to study activity of areas deep inside the brain, such as the thalamus and nucleus accumbens. The findings will help shed new light on disorders that affect these brain regions, such as Parkinson's disease and OCD. ... read more
    Source: Neuro Science NewsPublished on 2019-02-27By Neuroscience News
  • Study Reveals Structure of the Second Human Cannabinoid Receptor
    Researchers have identified the structure of the human type 2 cannabinoid receptor. The findings, researchers say, can help in the development of new treatments for inflammatory and neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-02-27By Neuroscience News
  • Not All Sleep is Equal When it Comes to Cleaning the Brain
    Study reinforces and explains the links between sleep deprivation and neurodegenerative diseases, researchers say. ... read more
    Source: Neuro Science NewsPublished on 2019-02-27By Neuroscience News
  • New treatment under trial could restore brain cells in Parkinson’s
    A series of clinical trials have concluded that a new therapy, alongside a novel method of delivery, could be effective in treating Parkinson's disease. ... read more
    Source: Medical News DailyPublished on 2019-02-27
  • New treatment offers potentially promising results for the possibility of slowing, stopping, or even reversing Parkinson’s disease
    A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Parkinson's disease. The study investigated whether boosting the levels of a naturally-occurring growth factor, Glial Cell Line Derived Neurotrophic Factor (GDNF), can regenerate dying dopamine brain cells in patients with Parkinson's and reverse ... read more
    Source: Science DailyPublished on 2019-02-27
  • New treatment offers potentially promising results for the possibility of slowing, stopping, or even reversing Parkinson’s disease
    (IOS Press) A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Parkinson's disease. The study investigated whether boosting the levels of a naturally-occurring growth factor, Glial Cell Line Derived Neurotrophic Factor (GDNF), can regenerate dying dopamine brain cells in patients with Parkinson's ... read more
    Source: Eureka AlertPublished on 2019-02-27
  • Lab study: Parkinson’s researchers test a new approach against motor disorders
    (DZNE - German Center for Neurodegenerative Diseases) Scientists of the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have been able to alleviate motor disorders in mice that resemble those seen in Parkinson's patients. ... read more
    Source: Eureka AlertPublished on 2019-02-27
  • New Treatment Offers Potentially Promising Results for the Possibility of Slowing, Stopping, or Even Reversing Parkinson’s Disease
    The three-part multimillion-pound GDNF study was funded by Parkinson’s UK with support from The Cure Parkinson’s Trust and in association with the North Bristol NHS Trust. Six patients took part in the initial pilot study to assess the safety of the treatment approach. A further 35 individuals then participated in the nine-month double blind trial, in which half were randomly ... read more
    Source: IOS PressPublished on 2019-02-26By Carmel McNamara
  • A reward now or later? Exploring impulsivity in Parkinson’s disease patients
    (Scuola Internazionale Superiore di Studi Avanzati) Promises of food, sums of money or entertaining pastimes: it does not matter what the temptation is, a new study shows that patients suffering from Parkinson's disease who are treated with DBS of the subthalamic nucleus are not more impulsive than others when making decisions about an appealing stimulus. To establish this, in the ... read more
    Source: Eureka AlertPublished on 2019-02-25
  • A reward now or later? Exploring impulsivity in Parkinson’s disease patients
    (Scuola Internazionale Superiore di Studi Avanzati) Promises of food, sums of money or entertaining pastimes: it does not matter what the temptation is, a new study shows that patients suffering from Parkinson's disease who are treated with DBS of the subthalamic nucleus are not more impulsive than others when making decisions about an appealing stimulus. To establish this, in the ... read more
    Source: Eureka AlertPublished on 2019-02-25
  • Mental and Physical Activity in Middle Age Tied to Lower Dementia Risk
    According to researchers, keeping both physically and mentally active during middle age can significantly reduce the risk of developing dementia during old age. The study found women who participated in mental activities were 46% less likely to develop dementia, and those who were physically active at a 52% reduced risk. ... read more
    Source: Neuro Science NewsPublished on 2019-02-23By Neuroscience News
  • One ring to rule them all
      An important aspect of developing new potentially ‘curative’ treatments for Parkinson’s is our ability to accurately test and evaluate them. Our current methods of assessing Parkinson’s are basic at best (UPDRS and brain imaging), and if we do not improve our ability to measure Parkinson’s, ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-02-23By Simon
  • How Blood Vessels Protect the Brain During Inflammation
    A new study reveals how blood vessels help protect the brain during inflammation. The findings could help in the development of new treatments for neurodegenerative and autoimmune diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-02-22By Neuroscience News
  • A focus on GBA-Parkinson’s
          This week the ‘Michael J. Fox Foundation for Parkinson’s Research’ and ‘The Silverstein Foundation for Parkinson’s with GBA’ announced that they are collaboratively awarding nearly US$3 million in research grants to fund studies investigating an enzyme called beta glucocerebrosidase (or GCase). Why ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-02-21By Simon
  • Can a Nerve Injury Trigger ALS?
    A new study reveals peripheral nerve damage may trigger the onset and spread of ALS in mouse models of the neurodegenerative disease. ... read more
    Source: Neuro Science NewsPublished on 2019-02-20By Neuroscience News
  • Altered Brain Activity Patterns of Parkinson’s Captured in Mice
    Researchers have pinpointed how brain activity changes in mouse models of Parkinson's disease, providing clues as to what may drive symptoms of the disease in humans. ... read more
    Source: Neuro Science NewsPublished on 2019-02-19By Neuroscience News
  • Altered brain activity patterns of Parkinson’s captured in mice
    Researchers pinpoint how brain activity changes in mouse models of Parkinson's disease, hinting at what may drive symptoms in humans. ... read more
    Source: Science DailyPublished on 2019-02-19
  • Shimmer launches Verisense™ wearable sensor platform for clinical trials
    (Rana Healthcare Solutions LLC) Shimmer, a global leader in wearable technology for research applications, today launched Verisense™, its next-generation wearable sensor platform designed from the ground up to meet the needs of clinical trial sponsors, sites and participants. Verisense is a comprehensive and flexible solution for reliably capturing accurate and complete biometric data. Starting in March, Shimmer customers are planning ... read more
    Source: Eureka AlertPublished on 2019-02-19
  • Altered brain activity patterns of parkinson’s captured in mice
    (Okinawa Institute of Science and Technology (OIST) Graduate University) Researchers pinpoint how brain activity changes in mouse models of Parkinson's disease, hinting at what may drive symptoms in humans. ... read more
    Source: Eureka AlertPublished on 2019-02-19
  • Clinical trials: Trying to make them SEAMless
      The clinical testing new compounds is horrifically slow. There is simply no easy way to word it. From lab bench to regulator approval, we are currently looking at a process which will take at least a decade. The repurposing of clinically available treatments has ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-02-18By Simon
  • Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis
    Researchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sensitive MRI (NM-MRI) -- is a potential biomarker for psychosis. NM-MRI signal was found to be a marker of dopamine function in people with schizophrenia and an indicator of the severity of psychotic symptoms in people with this mental illness. ... read more
    Source: Science DailyPublished on 2019-02-18
1 2 3 4 5 57